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Background: Ziziphora tenuior L. (Kakuti in Persian) is used in traditional medicine for treatment of gastrointestinal
disorders as carminative and analgesic plant. The other usages of this plant are included treatment of diarrhea and
nausea. Therefore in the present study we evaluated the immunomodulatory effects of the ethanolic extract of this
plant on the dendritic cells (DCs).
Results: Ziziphora tenuior L. extract significantly (p = 0.002) increased the level of surface expression of CD40 as an
important co-stimulatory marker on DCs compared to the control. However this extract did not change CD86 and
MHC-II molecules, so it could promote DCs phenotypic maturation. Treatment of DCs with the extract resulted in
slightly increased of the production of (IL-12); however, this change was not significant. In addition, the ability of
treated DCs to stimulate allogenic T cells proliferation and cytokines secretion was examined in the co-cuture of
these cells with T cells in mixed lymphocyte reaction (MLR). Z. tenuior L. at the 100 μg/ml concentration inhibited
the proliferation of allogenic T cells and also significantly (P < 0.001) increased the level of IL-10. Moreover, the
extract at 10–100 μg/ml concentration caused slightly increase in IFN-γ production and decreased IL-4 cytokines
but these changes were not significant.
Conclusions: These findings indicated that Z. tenuior L. extract can modulate immune response by induction of
CD40 expression on DCs and cytokine production; whereas it can inhibit T cell stimulating activity of DCs in high
concentration. These findings possibly in part explain the traditional use of this plant in treatment of
immune-mediated disorders. However future studies are needed.
Keywords: Ziziphora tenuior L, Immunomodulation, Dendritic cells, T cell responses, CytokineIntroduction
Medicinal plants are used to treat immune disorders, such
as inflammatory and autoimmune diseases in the world-
wide. Previous studies showed that some herbal medicine
have immunomodulatory effects [1,2]. Ziziphora genus
(Lamiacaea) is included of four species namely Z. tenuior
L., Z.capitata L., Z.clinopodioides and Z. Persica Bunge
[3]. Ziziphora or Kakuti in Iranian traditional medicine is
recognized to dried aerial parts of Z. tenuior L. which con-
tains at least 1.2% (volum/weight) of the essential oil [4].
This medicinal plant distributed widely in Iran, Pakistan,
Turkmenistan, Afghanistan, Armenia, Anatolia, Syria,
Transcaucasia and Central Asia [3]. In traditional medi-
cine, Ziziphora is used to treat dysentery, fever, uterus in-
fection and also as analgesic plant [5]. In addition, it is* Correspondence: shahnazi58@yahoo.com
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article, unless otherwise stated.used in the treatment of the gastrointestinal disorder
as carminative or treat of vomiting or diarrhea [6,7].
Phytochemical analysis indicated that major components
of its essential oil are pulegone, isomenthone, thymol,
menthone and piperitone [7-10]. Previous studies showed
that these compounds are suggested to be responsible for
the mentiond medicinal properties. It has been shown
that, Ziziphora clinopoides methanolic extract inhibited
inflammatory mediators in dextran sodium sulfate in-
duced colitis in mice and also protected acetic acid-
induced toxic bowel inflammation through reduction of
cellular lipid peroxidation and myeloperoxidase activity
[11,12]. On the other hand, Dendritic cells are potential
antigen presenting cells for naive T cells and act as a link
between the acquired and innate immune systems for
the initiation of the protective immune response or the
induction of immune tolerance [13]. Maturation status,
origin and phenotype are affected on the function oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Azadmehr et al. DARU Journal of Pharmaceutical Sciences 2014, 22:63 Page 2 of 6
http://www.darujps.com/content/22/1/63these cells [14]. The nature of the cytokines produced
by DCs in response to various ligands eventually modu-
lates and determines the type of Th cell response. DCs
have the exclusive ability to stimulate naive T cells to ei-
ther Th1 or Th2 cells and also effectively down-regulate
T-cell responses through the generation of T regulatory
cells [15,16]. It has been demonstrated that immature
DCs can effectively present antigen to naive T cells but
because of low expression of co-stimulatory molecules
such as CD40, CD86 and MHC II they cannot suitably
stimulate immune system, finally T cells activation and
proliferation are inhibited [14]. In this regards, maturation
of DCs converts them to the cells that can stimulate im-
mune system. So, the use of these cells as therapeutic
targets by pharmacological compounds such as medi-
cinal plant is a valuable strategy to modulate immune
responses. In the present study we have evaluated the
immunomodulatory effects of Z. tenuior L. extract on
the function and maturation of DCs.
Materials and methods
Animals
The male BALB/c and C57BL/6 mice with 6–8 week old
were purchased from Razi Institute (Karaj, Iran) and
were kept under optimal conditions of hygiene and re-
ceived standard mouse chow and water ad libitum. In this
study, all experimental procedures on handling the ani-
mals were approved by the ethical committee of Qazvin
University of Medical Sciences.
Preparation of DCs from mice spleen
To isolate DCs from spleen, the mice CD11c+ isolation
kit (Miltenyi Biotech, Germany), was used as described
in previous study [17]. Briefly, the mice spleens were iso-
lated and minced to very small pieces and then suspended
in cold (4°C) PBS containing 1.2 mg/ml collagenase D
(Roche, Germany).The cell suspension, incubated at 37°C
for 40 minutes and was passed through a cell mesh and
the collected cells were washed twice. Then, mononuclear
cells (MNC) were separated by Nycodenz (Axis-shield,
Norway); a material used in density gradient cell separ-
ation techniques. According to the manufacturer’s
protocol, anti-CD11c magnetic beads (Miltenyi Biotech,
Germany) were added to the cells and incubated at 4°C
for 30 minutes and the non-bonded antibodies were
washed out. Using of the minimacs separator (MS) cell
columns into the magnetic field (MS separation unit,
Miltenyi Biotech, USA) and washed by 1.5 ml EDTA-
containing PBS and then passed through the column to
absorb the magnetic bead coated DCs and the unwanted
cells were washed out using at least 3 washes of 500 μl
EDTA-containing PBS. The isolated DCs were collected
by disconnecting the column from the magnetic field
and injecting 1 ml PBS-EDTA in it under pressure.Purity of the CD11c dendritic cells was determined
above 94% using flow cytometry.
Plant material and preparation of the ethanolic extract
Ziziphora tenuior was purchased from herbal market
and authenticated by a botanist. Voucher specimens
were preserved in the central herbarium of medicinal
plants (ACECR). The aerial parts of plant were air-dried
at room temperature. This was ground in to powder.
The aerial part of plant (50 g) was extracted using percola-
tion method by ethanol (80%) at room temperature. Solv-
ent was completely removed by drying under reduced
pressure at 40°C in a rotary evaporator. The samples were
stored at 4°C until use (3 g, 6% yield) [18].
Effect of extract on DCs viability
To determine, the effect of cytotoxic concentration
of the extract on DCs, 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) colorimetric assay
was used [15]. Briefly, dendritic cells (105 cells/well) were
treated with Z. tenuior L. extract at 10 to 200 μg/ml con-
centrations in the cell culture plates for 24 h, and then
10 μl MTT (5 mg/ml, Sigma) was added to each well and
cells were incubated for an additional 4 h at 37°C. Di-
methyl sulphoxide (DMSO 0.1%) as vehicle and lipopoly-
saccharides (LPS 1 μg/ml) as DC maturation inducing
agent, were used as negative and positive controls, re-
spectively. Finally, the optical density (OD) of each well
was measured at 570 with reference at 630 nm on an
enzyme-linked immuosorbent assay (ELISA) plate reader
and the viability was determined as the follows: (OD of
extract-treated cells/OD of DMSO-treated cells) × 100.
Analysis of markers expression of co-stimulatory
molecules
In order to evaluate the effect of Z. tenuior L. on the
expression of co-stimulatory molecules, DCs were treated
with the extract for 18 h and analyzed using flow cyt-
ometer (FACSCalibur, Beckton Dickinson Biosciences,
San Jose, CA). The cells were stained with phycoerithrin
(PE)-conjugated anti-CD11c, FITC-conjugated anti-CD86,
fluorescence isothiocyanate (FITC)-conjugated anti-CD40,
FITC-conjugated anti-MHC II antibody and appropriate
conjugated isotypes (Beckton Dickinson (BD) Pharmino-
gen, San Diego, CA). Finally, the percentage of markers
expression on extract-treated DCs and DMSO-treated
DCs was calculated and the mean florescent intensity
(MFI) was analyzed using Win MDI software (Scripps, La
Jolla, CA).
Mixed lymphocyte reaction
To determine the proliferative effect of Z. tenuior L.
extract-treated DCs on T lymphocytes, allogeneic mixed
lymphocyte reaction (MLR) assay was used. Briefly, T cells
Figure 1 DCs viability after treatment with Z. tenuior L. extract.
MTT assay was used for determining of DCs viability. These cells
were treated with different concentrations of the plant extract for
24 h. DCs treated with DMSO was used as control. The results show
mean ± standard deviation of three independent experiments
performed in triplicate. The extract at 10 to 100 μg/ml had no
significant growth inhibitory effects on DCs. *Significantly (P < .0.05)
different was between the extract-treated cells and the control cells.
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nylon wool. Then, Z. tenuior L -treated DCs from BALB/c
mice were inactivated with mitomycin C (0.5 mg/ml) for
20 min, and then cells were washed with phosphate buff-
ered saline (PBS) for three times and resuspended in cul-
ture medium containing 10% FCS. Mitomycin-treated
DCs (104 cells/well), as stimulator cells, co-cultured with
105 allogenic T cells, as responder cells, in a 96-well cul-
ture plate (Nunc, Denmark) in triplicates for 48 h. As
negative control, a triplicate wells containing DMSO-
treated DCs plus allogenic T cells were used. Finally, T cell
proliferation was measured by a 5-Bromo-20-deoxy-
uridine (BrdU) cell proliferation assay kit (Roche, Germany)
according to the manufacturer’s instructions. The result
was concluded as the follows: (OD of extract-treated cul-
ture/OD of DMSO-treated culture) × 100.
Effect of the extract on the cytokines production
In order to evaluate immunomodulatory effect of Z. tenuior
L. extract on the cytokines production, the enzyme-linked
immunosorbent assay (ELISA) method was used. Briefly,
the supernatant of extract-treated DCs and MLR cultures
were collected and used to measure IFN-γ, IL-4, IL-12
and IL-10 by ELISA kits according to the manufacturer’s
protocol (eBioscience, USA), respectively.
Statistics analysis
In this study, all data were representative of at least
three independent experiments performed in triplicate
and presented as mean ± standard deviation (SD). Mann–
Whitney test and one-way analysis of variance (ANOVA)
were used for the evaluation of statistical differences be-
tween the results and p vales less than 0.05 were consid-
ered significant.
Results
Viability of DCs after exposure with Z. tenuior L. extract
The DCs viability was determined using MTT assay. For
this purpose, these cells were treated with different con-
centrations of the plant extract for 24 h. Our results indi-
cated that this extract at concentration of 10, 50 and
100 μg/ml had no cytotoxic effect on DCs (Figure 1) how-
ever the extract at 200 μg/ml had significantly (P < 0.05)
cytotoxic effect on DCs. Therefore these concentrations
(10 to 100 μg/ml) were used as safe dose of Z. tenuior L.
extract for the next experiments on DCs.
Effect of Z. tenuior L. extract on maturation phenotype of
DCs
We analyzed the percentage expression and fluorescent
intensity of CD86, CD40 and MHC II co-stimulatory
molecules on Z. tenuior L-treated DCs by flow cytome-
try. Our results showed that the extract modulate the
percentage expression and fluorescent intensity of CD86,CD40 and MHC II molecules on DCs. As shown in
Figure 2, this extract significantly (P = 0.002) increased
the percentage expression of CD40 molecules at 100 μg/ml
compared with negative control. Although, Z. tenuior L.
Extract increased the percentage expression and fluores-
cent intensity of CD86 and MHC II on DCs but this effect
was not significant comparing with control. These finding
showed that Z. tenuior L. extract can modulate the matur-
ation phenotype markers on DCs.
Effect of Z. tenuior L. extract on allogenic MLR
To determine the effects of the Z. tenuior L. extract on
allogenic immune response and DCs function, the allo-
genic T cells from C57BL/6 were co-cultured with DCs
isolated from BALB/c mice. For this purpose, the DCs
were treated with concentrations of 10 to 100 μg/ml of
the extract for 18 h and then cells were co-cultured with
allogenic T cells in MLR assay. Finally, the proliferation
of T lymphocytes was evaluated using BrdU incorpor-
ation assay. As it is shown in Figure 3, the Z. tenuior L.
extract significantly (p < 0.05) decreased the proliferation
of T cells at 100 μg/ml. The results indicated that the
proliferation of these cells decreased to 76.8 ± 3.4 percent
of control when DCs had been treated with 100 μg/ml of
the extract concentration.
Effect of Z. tenuior L. on the production of cytokines
The concentration of the IL-12 cytokine in the super-
natant of the extract-treated DCs was measured. As
shown in Figure 4A, treatment of DCs with this extract
at 10 to 100 μg/ml resulted in slightly increase of pro-
duction of IL-12 by these cells comparing with the nega-
tive control. However this change was not significant. In
Figure 2 Effect of Z. tenuior L. extract on maturation phenotype of DCs. In order to determine the effect of Z. tenuior L. extract on
maturation phenotype on DCs, these cell were treated with the extract for 18 h and then the expression of CD40, CD86 and MHC II molecules
was determined by flow cytomety. DC treated with DMSO as negative control and also lipopolysaccharides (LPS 1 μg/ml) as positive control
were considered. The results show mean ± standard deviation of three independent experiments performed in triplicate. *Significantly (P < 0.05)
different was between the extract-treated cells and the negative control cells.
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IL-4 and IL-10 production in MLR. We found that, the
extract at 10–100 μg/ml concentrations slightly increased
production of IFN-γ and decreased IL-4 cytokines but
these changes were not significant (Figure 4B, C). How-
ever, as it is shown in Figure 4D, our result indicated thatFigure 3 The effect of Z. tenuior L. extract on allogenic MLR.
In order to find the effects of the Z. tenuior L. extract on allogenic
immune response, DCs were treated with the extract for 18 h and
then co-cultured with allogenic T cells for 48 h. DMSO-treated DCs
plus T cells was considered as control. Brdu incorporation assay was
used for measuring of cell proliferation. The results show mean ± SD
of the cell proliferation in the presence of the extract as compared
to the proliferation of controls taken to be 100%. Our results
indicated that DCs treated with 100 μg/ml of extract significantly
(*P < 0.05) have decreased T cells proliferation.the Z. tenuior L. extract at 100 μg/ml concentration sig-
nificantly (p < 0.05) increased IL-10 cytokine production.
Discussion
In this study, we evaluated the immunomodulatory effects
of Z. tenuior L. extract on the DCs. Several studies showed
that natural agents such as plants can modulate DCs ac-
tivity [19-21]. Dendritic cells are professional antigen pre-
senting cells for naive T cells and act as a link between the
acquired and innate immune systems for the initiation of
the protective immune response or the induction of im-
mune tolerance [13]. Therefore, to find out the new DCs
immunomodulaters are considered as the important tar-
gets for immune response as well as immune regulation.
Ziziphora is used to treat dysentery, fever, uterus infection
and also analgesic plant in traditional medicine [5]. In
addition, it is used in the treatment of the gastrointestinal
disorder as carminative or treat of vomiting or diarrhea
[6,7]. It has been shown that, Ziziphora clinopoides metha-
nolic extract inhibited inflammatory mediators in dextran
sodium sulfate induced colitis in mice and also protected
acetic acid-induced toxic bowel inflammation through re-
duction of cellular lipid peroxidation and myeloperoxidase
activity [11,12].
In the present study, we examined the effect of the Z.
tenuior L. extract on the phenotypic maturation and func-
tion of DCs. The expression of CD86, CD40 and MHC- ІІ
molecules are important co-stimulatory and maturation
Figure 4 Effect of Z. tenuior L. extract on cytokine production. The effect of the Z. tenuior L. extract on IL-12 production by DCs after 18 h
showed in Figure 4A. DMSO treated DCs as control negative (C neg) and LPS as positive control (C pos) were considered. Moreover, the effect of
the extract on IFN- γ, IL-4 and IL-10 production in MLR assay showed in Figure 4B, C and D. DMSO-treated DCs plus allogenic T cells as Control
considered. *P < 0.05 shows significant difference with the negative control.
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tation and T cell activation. Our results showed that the
extract modulate the percentage expression and fluores-
cent intensity of CD86, CD40 and MHC II molecules on
DCs. Previous studies indicated that some herbal extracts
can modulate immune response by immunomodulatory
effect on the CD40 expression on the dendritic cells
[22,23]. Our results showed that the extract significantly
increased the percentage expression of CD40 molecules at
100 μg/ml compared with control negative. Although, Z.
tenuior L. extract increased the percentage expression and
fluorescent intensity of CD86 and MHC II on DCs but
this effect was not significant comparing with control.
These finding indicated that Z. tenuior L. extract can
modulate the maturation phenotype markers on DCs.
In addition, we evaluated the immunomodulatory effect
of Z. tenuior L. extract on the DCs functions by releasing
of cytokines and MLR. IL-12 is a cytokine released by DCs
which can induce differentiation of T cells to Th1 and cel-
lular immunity, by contrast IL-10 is a Th1 inhibitory cyto-
kine and also, IL-4 and IFN-γ cytokines are landmark of
deviation to Th1 or Th2 response [24]. Our results indi-
cated that the treatment of DCs with this extract at 10 to
100 μg/ml concentration increased production of IL-12
comparing with the negative control however this change
was not significant. Also, the extract at 10–100 μg/ml con-
centrations increased production of IFN-γ and decreased
IL-4 cytokines but these changes were not significant.
However, our result indicated that the Z. tenuior L. extractat 100 μg/ml concentration significantly increased IL-10
cytokine production. We assumed that the increased
IL-12 production by DCs using 10–100 μg/ml extract
concentration along with production of more IFN-γ and
less IL-4 by T cells in MLR suggest the ability of Z.
tenuior L. extract to deviate the cytokine pattern of T
cells toward a Th1 response. However, the extract at
100 μg/ml concentration has increased IL-10 secretion
in MLR and also reduced the proliferation of T cells in
allogenic response, which indicated the inhibitory effect
of the extract at higher concentration on the immune
response. Moreover, the difference between the effects
of the extract at higher concentrations may be attributed
to the presence of various constituents in the extract with
different mode of actions. So, to confirm Th1/Th2
polarization in co-culture of T cells with Z. tenuior L.
treated-DCs, study of the T cell signaling activity of
DCs and the expression of T bet and GATA-3 as related
transcription factors for Th1 and Th2 differentiation is
recommended [25]. Future studies are suggested for iden-
tifying the main bioactive compound of this plant and
other immunomodulatory mechanisms.
Conclusions
Our findings indicated that Z. tenuior L. extract can
modulate immune response by induction of CD40 ex-
pression on DCs and cytokine production; whereas it
can inhibit T cell stimulating activity of DCs in high
concentration. These findings possibly in part explain
Azadmehr et al. DARU Journal of Pharmaceutical Sciences 2014, 22:63 Page 6 of 6
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mediated disorders. However future in vitro and in vivo
studies are needed.
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